Dimora Medical has launched MegaSorb technology, designed for use in silicone foam dressings.
The company announced the development as demand for advanced wound care solutions continues to rise.
MegaSorb is designed to enhance absorption efficiency, manage exudate effectively, and improve patient comfort.
The MegaSorb dual-action absorption system is a key feature of this product launch. It uses a high-porosity polymer foam, MegaSorb Foam, with an open-cell structure of up to 90%.
The structure is designed to enable rapid uptake of wound exudate while maintaining the dressing’s internal stability during use.
MegaSorb Foam can absorb up to 15 times its own weight in fluid. The company states that this addresses the needs of wounds with moderate to high exudate levels.
Dimora Medical highlights the system’s ability to rapidly retain and control fluid. The company claims that exudate can be locked within the dressing within as little as one second of entering the foam structure.
This rapid containment aims to reduce leakage and backflow, helping maintain dressing integrity and minimise disruptions from seepage or frequent dressing changes.
The system combines fast absorption with rapid internal retention to help maintain a consistent wound environment.
The company indicates that the launch of MegaSorb reflects its ongoing focus on material innovation and the development of product systems for wound care.
Dimora Medical aims to support recovery and chronic care by developing solutions that simplify caregiving, particularly for middle-aged and elderly patients who need long-term support.
